Structure Therapeutics' Phase 2 data for Aleniglipron show 16% weight loss at 44 weeks with strong tolerability and no safety ...
A new U.S. bill targeting unregulated competitors creates a market advantage for established sports betting leaders ...
The name might sound like a Nordic god, but it is actually the molecular machinery that allows many different species to eat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results